Xu D

2.3k total citations
135 papers, 1.7k citations indexed

About

Xu D is a scholar working on Molecular Biology, Epidemiology and Rheumatology. According to data from OpenAlex, Xu D has authored 135 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 31 papers in Epidemiology and 23 papers in Rheumatology. Recurrent topics in Xu D's work include Inflammatory Myopathies and Dermatomyositis (18 papers), Systemic Sclerosis and Related Diseases (10 papers) and RNA Interference and Gene Delivery (9 papers). Xu D is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (18 papers), Systemic Sclerosis and Related Diseases (10 papers) and RNA Interference and Gene Delivery (9 papers). Xu D collaborates with scholars based in China, United States and Belgium. Xu D's co-authors include R. L. Juliano, Peiheng He, Michael H. Fisher, Xiaofeng Zeng, Ziji Zhang, Qian Wang, Mengtao Li, Andrea Kovács, Zhiliang Li and Suraiya Rasheed and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Xu D

125 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu D China 24 751 282 253 248 242 135 1.7k
Qian Chen China 25 928 1.2× 342 1.2× 359 1.4× 187 0.8× 161 0.7× 75 2.1k
Yujia Li China 21 854 1.1× 399 1.4× 352 1.4× 362 1.5× 126 0.5× 95 1.8k
Ninghan Feng China 27 1.4k 1.8× 575 2.0× 248 1.0× 271 1.1× 401 1.7× 126 2.2k
Zhirong Zeng China 24 747 1.0× 297 1.1× 220 0.9× 152 0.6× 277 1.1× 70 1.5k
Qiao Zhou China 21 401 0.5× 161 0.6× 289 1.1× 118 0.5× 154 0.6× 103 1.2k
Zheng Lin China 25 748 1.0× 298 1.1× 245 1.0× 257 1.0× 152 0.6× 128 1.7k
Fei Gao China 29 1.2k 1.6× 448 1.6× 126 0.5× 333 1.3× 228 0.9× 114 2.6k
Nahid Eskandari Iran 20 656 0.9× 270 1.0× 197 0.8× 97 0.4× 222 0.9× 101 1.6k
Seppo T. Nikkari Finland 27 730 1.0× 799 2.8× 233 0.9× 276 1.1× 236 1.0× 100 2.7k

Countries citing papers authored by Xu D

Since Specialization
Citations

This map shows the geographic impact of Xu D's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu D with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu D more than expected).

Fields of papers citing papers by Xu D

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu D. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu D. The network helps show where Xu D may publish in the future.

Co-authorship network of co-authors of Xu D

This figure shows the co-authorship network connecting the top 25 collaborators of Xu D. A scholar is included among the top collaborators of Xu D based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu D. Xu D is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xinzhuang, Yu Chen, Xiuling Zhang, et al.. (2025). The Prospective Registry of MyositIS (PROMIS): I. Next-generation sequencing identifies HLA-DQA1 as a novel genetic risk of anti-MDA5 antibody-positive dermatomyositis. Annals of the Rheumatic Diseases. 84(7). 1221–1230.
2.
Zhao, Peng, Shuang Zhou, Chanyuan Wu, et al.. (2024). Global trends in research of melanoma differentiation-associated gene 5: a bibliometric analysis from 2002 to 2022. Clinical Rheumatology. 43(3). 1111–1126. 1 indexed citations
3.
D, Xu, et al.. (2024). Identification of middle cerebral artery stenosis in transcranial Doppler using a modified VGG-16. Frontiers in Neurology. 15. 1394435–1394435. 3 indexed citations
4.
Du, Chenlin, Xiaofeng Zeng, Qian Wang, et al.. (2024). Characterization of kidneys in patients with systemic sclerosis by multi-parametric magnetic resonance quantitative imaging. Magnetic Resonance Imaging. 109. 203–210. 3 indexed citations
5.
Liu, Tianqi, et al.. (2024). Research progress on pathogenesis of skin pigmentation in chronic liver disease. SHILAP Revista de lepidopterología. 25(6). 1218–1232. 1 indexed citations
6.
Zhou, Shuang, Qiao Lin, Jiuliang Zhao, et al.. (2023). Non-apoptotic programmed cell deaths in diabetic pulmonary dysfunction: the new side of advanced glycation end products. Frontiers in Endocrinology. 14. 1126661–1126661. 6 indexed citations
7.
D, Xu, et al.. (2020). Risk factors for retinal vein occlusion and central retinal thickness. SHILAP Revista de lepidopterología. 1 indexed citations
8.
Ge, Wei, et al.. (2020). Establishment of Simple Nomograms for Predicting Axillary Lymph Node Involvement in Early Breast Cancer. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Luo, Yanping, et al.. (2020). Experimental Study of Tumor Therapy Mediated by Multimodal Imaging Based on a Biological Targeting Synergistic Agent. Dove Medical Press (Taylor and Francis Group). 2 indexed citations
10.
D, Xu, et al.. (2019). HIF1α/PD-L1 axis mediates hypoxia-induced cell apoptosis and tumor progression in follicular thyroid carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Kuang, Yanbin, Wenzheng Guo, Ling Jing, et al.. (2019). Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway. Cell Death and Disease. 10(4). 297–297. 46 indexed citations
12.
Sun, Yao, et al.. (2017). NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Wei, Lei, et al.. (2015). Comprehensive analysis of gene-expression profile in chronic obstructive pulmonary disease. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Jiang, Jing, et al.. (2014). [Effect of Modified Zhisou Powder on the lung function of chronic obstructive pulmonary disease model rats of northwest China cold dryness syndrome].. PubMed. 34(5). 556–61. 2 indexed citations
15.
Luo, Xiaofang, Mengtao Li, Xu D, et al.. (2014). Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model. PLoS ONE. 9(12). e114792–e114792. 62 indexed citations
16.
D, Xu, et al.. (2013). Analysis of the metabolic properties of maintenance hemodialysis patients with glucose-added dialysis based on high performance liquid chromatography quadrupole time-of-flight mass spectrometry. SHILAP Revista de lepidopterología.
17.
Yang, Zhichao & Xu D. (2009). Periodic Solutions and Stability of Impulsive Type Competition System with Infinitely Distributed Delays and Feedback Controls. Acta Mathematicae Applicatae Sinica English Series. 2 indexed citations
18.
D, Xu, et al.. (1998). [The study on detection of human parvovirus B19 DNA in spontaneous abortion tissues].. PubMed. 12(2). 158–60. 2 indexed citations
19.
D, Xu. (1985). A THEOREM FOR STABILITY OF LINEAR DISCRETE SYSTEMS. 科学通报(英文版). 2 indexed citations
20.
D, Xu. (1983). STABILITY OF LINEAR TIME VARYING SYSTEMS. 科学通报(英文版). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026